Back to search

Japan· JP-6125400D4029

コリスチンメタンスルホン酸ナトリウム

A colistin product containing コリスチンメタンスルホン酸ナトリウム, registered in Japan by グラクソ・スミスクライン, on the national reimbursement list.

On Japan’s NHI price listATC A07AA10

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedコリスチンメタンスルホン酸ナトリウムATCA07AA10REGISTER NO.JP-6125400D4029PACKS LISTED0CHECKEDSeptember 25, 2026

The record

At a glance

MHLW / PMDA (Japan)
Active substance
コリスチンメタンスルホン酸ナトリウム
Manufacturer
グラクソ・スミスクライン
Country
Japan (JP)
ATC code
A07AA10
ATC class
Colistin
Defined daily dose
9 MIO, E
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under A07AA10

Colistin, as other registers publish it.

All colistin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e81a4600-c94a-4fd4-b896-cbb171f9e65a
GET /v1/drugs/e81a4600-c94a-4fd4-b896-cbb171f9e65a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "150mg1瓶",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "6125400D4029",
  "category": "注射薬",
  "price_yen": 8414,
  "generic_name": "コリスチンメタンスルホン酸ナトリウム",
  "product_name_jp": null,
  "therapeutic_class": "6125",
  "transitional_expiry": null
}

See everything about colistin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.